Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 2,215 |
| Marketable Securities | 2,000 |
| Receivables | 447 |
| Inventories | 3,247 |
| TOTAL | $8,238 |
| Non-Current Assets | |
| PPE Net | 1,067 |
| Other Non-Current Assets | 513 |
| TOTAL | $1,580 |
| Total Assets | $9,818 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 219 |
| Accounts payable and accrued liabilities | 930 |
| Accrued Expenses | 1,678 |
| Other current liabilities | 27 |
| TOTAL | $3,208 |
| Non-Current Liabilities | |
| Long Term Debt | 293 |
| Deferred Revenues | 175 |
| Other Non-Current Liabilities | 89 |
| TOTAL | $1,098 |
| Total Liabilities | $4,306 |
| Shareholders' Equity | |
| Retained earnings | -34,736 |
| Other shareholders' equity | 39,612 |
| TOTAL | $5,512 |
| Total Liabilities And Equity | $9,818 |